Inhibitors of AKT activity

The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer c...

Full description

Saved in:
Bibliographic Details
Main Author BILODEAU MARK T.,CHEN CHIXU,COSFORD NICHOLAS D. P.,EASTMAN BRIAN W.,HARTNETT JOHN C.,HU ESSA H.,MANLEY PETER J.,NEILSON LOU ANNE,TEHRANI LIDA R.,WU ZHICAI
Format Patent
LanguageEnglish
Published 04.04.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Bibliography:Application Number: CN200580011984